RIKO OKAMOTO, None;
Osamu Sawada, bayer (R), kowa (R), novartis (F), novartis (R), santen (R), senju (R);
Yusuke Ichiyama, otsuka (R), topcon (R), zeiss (R);
Shumpei Obata, None;
Masashi Kakinoki, alcon (F), alconpharma (R), novartis (F);
Tomoko Sawada, allergan (R), bayer (R), novartis (R), santen (R);
Yoshitsugu Saishin, abbvie (R), alconjapan (F), bayer (R), eisai (R), novartis (F), novartis (R), santen (R);
Masahito Ohji, alconjapan (F), alconjapan (R), allergan (C), bayer (R), bayer (C), chuosangyo (R), HOYA (F), HOYA (C), kowa (R), novartis (F), novartis (R), novartis (C), otsuka (F), otsuka (R), pfizer (F), pfizer (R), RE (R), santen (F), santen (R), santen (C), senju (F), senju (R), topcon (R), zeiss (R)